+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Post-Traumatic Stress Disorder Therapeutics Market Report 2026 - Product Thumbnail Image

Post-Traumatic Stress Disorder Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Digital Biomarkers: Global Markets - Product Thumbnail Image

Digital Biomarkers: Global Markets

  • Report
  • July 2025
  • 129 Pages
  • Global
From
Precision Medicine Market Report 2025-2035 - Product Thumbnail Image

Precision Medicine Market Report 2025-2035

  • Report
  • June 2025
  • 463 Pages
  • Global
From
From
Protein Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Protein Therapeutics - Global Strategic Business Report

  • Report
  • March 2026
  • 181 Pages
  • Global
From
Biological Drugs - Global Strategic Business Report - Product Thumbnail Image

Biological Drugs - Global Strategic Business Report

  • Report
  • March 2026
  • 196 Pages
  • Global
From
From
From
Immunology Market 2024-2028 - Product Thumbnail Image

Immunology Market 2024-2028

  • Report
  • August 2024
  • 176 Pages
  • Global
From
From
Fibrotic Diseases Treatment Market - Global Forecast 2025-2032 - Product Thumbnail Image

Fibrotic Diseases Treatment Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 189 Pages
  • Global
From
From
Loading Indicator